Similar to the results of the pan-cancer analysis, LRP2 mutations in ECs also presented higher infiltration of CD8 T cell, plasma cells, and M1 macrophages than those without LRP2 mutations (Fig. S6A). The gene discussed is CD8A; the disease is cancer.